Chongqing University Three Gorges Hospital — Chongqing, Chongqing Municipality

Public research footprint of Chongqing University Three Gorges Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Diabetes Mellitus, Type 2 · Advanced Non-Small Cell Lung Cancer · Acute Ischemic Stroke Patients · Gastroesophageal Junction Adenocarcinoma

Recently updated registry entries

NCT07564466 — A Study of SKB571 in Participants With Gastrointestinal Tumors (Recruiting)
NCT04822181 — Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis… (Active Not Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Chongqing University Three Gorges Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.